The U.S. government has reached a settlement with Teva Pharmaceuticals Industries Ltd over charges that its agreements with rivals impeded consumer access to lower-priced generic drugs.
Source:: Reuters – Business News
Newswire
- [ January 2, 2025 ] N2OFF, Inc. (NASDAQ: NITO) Announces Its JV with Soltera Renewable Energy Ltd Obtained an Approval of 111 MWp Solar PV Project in Meltz Germany Newsmakers
- [ January 2, 2025 ] Expion360 (NASDAQ: XPON) to Begin Shipping e360 Home Energy Storage Solutions to Integration Partner Wellspring Solar Uncategorized
- [ January 2, 2025 ] Carmell (NASDAQ: CTCX) Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products Newsmakers
- [ December 30, 2024 ] Faraday Future (NASDAQ: FFIE) to Deliver FF 91 2.0 Futurist Alliance to Entrepreneur and Community Leader Luke Hans in January 2025 Newsmakers
- [ December 30, 2024 ] MicroCloud Hologram Inc. (NASDAQ: HOLO) Develops Semiconductor Quantum Dot Hole Spin Qubit Technology, Advancing the Frontiers of Quantum Computing Newsmakers
- [ December 12, 2024 ] Alternus Clean Energy Completes Acquisition of LiiON, a Leading US-Based Provider of Advanced Energy Storage Solutions Newsmakers
- [ December 3, 2024 ] Energous (NASDAQ: WATT) Awarded Scalable Multi-Phase Contract With Fortune 10 Retailer Newsmakers
- [ November 11, 2024 ] Horizon Aircraft (NASDAQ: HOVR) Simplifies Capital Structure with Mutual Termination of Forward Purchase Agreement with Meteora Capital Uncategorized
- [ November 11, 2024 ] CERo Therapeutics (NASDAQ: CERO0 Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity Newsmakers
- [ November 11, 2024 ] New World Solutions (OTC: REGRF) Launches E-commerce Platform Serving Luxury Watch Enthusiast Market Newsmakers
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.